Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$12.24
-3.9%
$13.76
$8.66
$19.14
$1.69B1.551.62 million shs1.29 million shs
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$20.00
$19.98
$12.26
$20.57
$843.96M0.74765,906 shs4,300 shs
Luminex Co. stock logo
LMNX
Luminex
$36.99
$36.90
$20.61
$41.69
$1.75B0.56873,093 shsN/A
Pulmonx Co. stock logo
LUNG
Pulmonx
$7.30
-2.9%
$9.34
$7.11
$14.84
$281.34M0.6500,414 shs194,703 shs
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$17.65
+0.5%
$17.52
$6.08
$45.08
$691.44M1.48793,087 shs619,729 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-1.47%+1.84%-6.39%-21.02%-14.78%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.00%0.00%0.00%0.00%+0.05%
Luminex Co. stock logo
LMNX
Luminex
0.00%0.00%0.00%0.00%0.00%
Pulmonx Co. stock logo
LUNG
Pulmonx
+0.27%+1.21%-15.79%-43.84%-35.73%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-0.57%+0.63%-4.67%+15.52%-60.51%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
4.2561 of 5 stars
3.52.00.03.31.95.00.6
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.2605 of 5 stars
0.00.00.04.20.01.70.6
Luminex Co. stock logo
LMNX
Luminex
N/AN/AN/AN/AN/AN/AN/AN/A
Pulmonx Co. stock logo
LUNG
Pulmonx
2.2409 of 5 stars
3.43.00.00.01.42.50.6
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
3.2301 of 5 stars
3.11.00.04.31.31.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
3.00
Buy$23.6393.01% Upside
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/A
Luminex Co. stock logo
LMNX
Luminex
N/AN/AN/AN/A
Pulmonx Co. stock logo
LUNG
Pulmonx
2.83
Moderate Buy$15.83116.89% Upside
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
2.18
Hold$22.1825.68% Upside

Current Analyst Ratings

Latest LUNG, ATEC, SILK, CSII, and LMNX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$17.00
3/28/2024
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$22.00 ➝ $23.00
3/20/2024
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00
3/20/2024
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$19.00 ➝ $22.00
3/7/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00
3/4/2024
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $23.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$10.00 ➝ $19.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$11.00 ➝ $18.00
2/28/2024
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00
2/23/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $17.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
$482.26M3.50N/AN/A$0.57 per share21.47
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$239.84M3.52N/AN/A$6.12 per share3.27
Luminex Co. stock logo
LMNX
Luminex
$417.40M4.19$1.12 per share32.98$11.13 per share3.32
Pulmonx Co. stock logo
LUNG
Pulmonx
$68.68M4.10N/AN/A$3.09 per share2.36
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$177.13M3.90N/AN/A$3.88 per share4.55

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$186.64M-$1.55N/AN/AN/A-38.70%N/A-27.93%5/7/2024 (Confirmed)
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
-$36.93M-$0.97N/AN/AN/A-15.79%-15.39%-11.93%N/A
Luminex Co. stock logo
LMNX
Luminex
$15.17M$0.3272.5330.83N/A5.39%4.66%2.91%N/A
Pulmonx Co. stock logo
LUNG
Pulmonx
-$60.84M-$1.60N/AN/AN/A-88.60%-46.63%-32.14%5/1/2024 (Confirmed)
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$55.74M-$1.44N/AN/AN/A-31.70%-36.38%-21.41%4/30/2024 (Confirmed)

Latest LUNG, ATEC, SILK, CSII, and LMNX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.33N/A+$0.33N/AN/AN/A  
5/1/2024N/A
Pulmonx Co. stock logo
LUNG
Pulmonx
-$0.43N/A+$0.43N/AN/AN/A  
4/30/2024N/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40N/A+$0.40N/AN/AN/A  
2/28/2024Q4 2023
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40-$0.33+$0.07-$0.33$42.23 million$47.27 million    
2/27/2024Q4 2023
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
-$0.28-$0.37-$0.09-$0.37$131.90 million$138.00 million    
2/21/2024Q4 2023
Pulmonx Co. stock logo
LUNG
Pulmonx
-$0.38-$0.36+$0.02-$0.36$18.24 million$19.30 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
N/AN/AN/AN/AN/A
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/AN/A
Luminex Co. stock logo
LMNX
Luminex
$0.401.08%N/A125.00%N/A
Pulmonx Co. stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
6.54
2.86
1.99
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.08
6.04
4.92
Luminex Co. stock logo
LMNX
Luminex
0.52
8.37
6.08
Pulmonx Co. stock logo
LUNG
Pulmonx
0.30
6.50
5.77
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.50
7.95
6.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
66.35%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
86.61%
Luminex Co. stock logo
LMNX
Luminex
87.76%
Pulmonx Co. stock logo
LUNG
Pulmonx
91.04%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/A

Insider Ownership

CompanyInsider Ownership
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
29.12%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
3.80%
Luminex Co. stock logo
LMNX
Luminex
6.60%
Pulmonx Co. stock logo
LUNG
Pulmonx
5.70%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
6.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
839137.98 million97.80 millionOptionable
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
78042.20 million40.59 millionOptionable
Luminex Co. stock logo
LMNX
Luminex
1,32547.31 millionN/AOptionable
Pulmonx Co. stock logo
LUNG
Pulmonx
27938.54 million36.34 millionOptionable
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
47439.18 million36.55 millionOptionable

LUNG, ATEC, SILK, CSII, and LMNX Headlines

SourceHeadline
Silk Road Medical to Present at the BofA Securities 2024 Healthcare ConferenceSilk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
globenewswire.com - April 23 at 4:30 PM
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to BuyAll You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
zacks.com - April 23 at 1:00 PM
Silk Road Medical (SILK) to Release Quarterly Earnings on TuesdaySilk Road Medical (SILK) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - April 23 at 4:32 AM
Silk Road Medical (SILK) to Release Earnings on TuesdaySilk Road Medical (SILK) to Release Earnings on Tuesday
marketbeat.com - April 23 at 4:30 AM
The Silk Road of the SeaThe Silk Road of the Sea
sundaytimes.lk - April 22 at 3:28 PM
Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.
nationalgeographic.com - April 22 at 3:28 PM
Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)
marketbeat.com - April 12 at 6:44 AM
Silk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from BrokeragesSilk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from Brokerages
marketbeat.com - April 12 at 2:17 AM
Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%
marketbeat.com - April 11 at 12:45 PM
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
globenewswire.com - April 9 at 4:30 PM
Silk Road Medicals (SILK) New Launch to Aid Its TCAR PortfolioSilk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
zacks.com - April 8 at 11:25 AM
China, Sri Lanka forging stronger bondsChina, Sri Lanka forging stronger bonds
chinadaily.com.cn - April 7 at 3:48 PM
Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%
marketbeat.com - April 5 at 3:45 PM
Taiwan Earthquake: What to Know About Travel and How to HelpTaiwan Earthquake: What to Know About Travel and How to Help
msn.com - April 5 at 1:08 AM
The One and Only Benedict WongThe One and Only Benedict Wong
vulture.com - April 4 at 7:57 AM
Silk Road Medical Launches Enroute Transcarotid NPS PlusSilk Road Medical Launches Enroute Transcarotid NPS Plus
evtoday.com - April 4 at 7:57 AM
Worker injured by electric shock from power line in BiddefordWorker injured by electric shock from power line in Biddeford
finance.yahoo.com - April 3 at 11:54 AM
Silk Road launches next-gen transcarotid neuroprotection systemSilk Road launches next-gen transcarotid neuroprotection system
massdevice.com - April 3 at 11:54 AM
Ancient People Also Had Sunburns, So They Used These 4 Forms of ProtectionAncient People Also Had Sunburns, So They Used These 4 Forms of Protection
msn.com - April 3 at 6:53 AM
Traditional Chinese medicine gains wider recognition around worldTraditional Chinese medicine gains wider recognition around world
sb.by - April 3 at 6:53 AM
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSSilk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
globenewswire.com - April 2 at 4:30 PM
Turkmenistan to launch traffic on Tejen - Mary expresswayTurkmenistan to launch traffic on Tejen - Mary expressway
en.trend.az - March 30 at 2:13 PM
Number of Russian Crocus City Hall terrorist attack victims increasesNumber of Russian Crocus City Hall terrorist attack victims increases
en.trend.az - March 30 at 2:13 PM
Rep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need A Global PerspectiveRep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need 'A Global Perspective'
theroot.com - March 29 at 2:31 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Alphatec logo

Alphatec

NASDAQ:ATEC
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Cardiovascular Systems logo

Cardiovascular Systems

NASDAQ:CSII
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.
Luminex logo

Luminex

NASDAQ:LMNX
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
Pulmonx logo

Pulmonx

NASDAQ:LUNG
Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Silk Road Medical logo

Silk Road Medical

NASDAQ:SILK
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.